-
- Comment on:
-
J Infect Dis. 2008 Feb 1;197(3):390-7.
Measuring HIV-1-specific T cell immunity: how valid are current assays?
PMID: 18184092 [PubMed - indexed for MEDLINE]
-
Cited by 2 PubMed Central articles
-
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
Boaz MJ, Hayes P, Tarragona T, Seamons L, Cooper A, Birungi J, Kitandwe P, Semaganda A, Kaleebu P, Stevens G, et al.
Clin Vaccine Immunol. 2009 Feb; 16(2):147-55. Epub 2008 Dec 17.
[Clin Vaccine Immunol. 2009]
-
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG.
J Virol. 2008 Jun; 82(11):5398-407. Epub 2008 Mar 19.
[J Virol. 2008]